Scopia Capital Management LP Intercept Pharmaceuticals, Inc. Transaction History

Scopia Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $2.66 Million - $6.52 Million	-54,942 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $106,230 - $229,833	-1,852 Reduced 3.26%	54,942 $6.81 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $4.42 Million - $6.85 Million	56,794 New	56,794 $4.52 Million
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $5.97 Million - $7.84 Million	-64,961 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$52.72 - $67.25 $3.42 Million - $4.37 Million	64,961 New	64,961 $4 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Scopia Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Scopia Capital Management LP with notifications on news.